Skip to content

Clinical trials

Observational Shock, Cardiogenic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Shock, Cardiogenic Phase: Observational Clear all

153 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20051
20061
20082
20105
20112
20123
20131
20141
20152
20169
201710
20185
201917
202014
202110
202214
202313
202415
202513
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting46
Completed45
Unknown status43
Not yet recruiting12
Active, not recruiting3
Terminated2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Central Hospital, Nancy, France7
University Hospital, Montpellier7
National Taiwan University Hospital4
University Hospital, Strasbourg, France4
Abiomed Inc.3
Charite University, Berlin, Germany3
Maastricht University Medical Center3
University Hospital, Bordeaux3
Assistance Publique - Hôpitaux de Paris2
Assistance Publique Hopitaux De Marseille2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Shock, Cardiogenic153
Heart Arrest22
Heart Failure21
Shock14
Myocardial Infarction13
Respiratory Distress Syndrome11
Shock, Septic10
Acute Coronary Syndrome9
Acute Kidney Injury6
ST Elevation Myocardial Infarction6

Trials

Showing 76 to 100 of 153. Each trial links to its page on Pharma Observatory.

53 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.